Application 091090
- Type
- ANDA
- Sponsor
- GLENMARK GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NORETHINDRONE ACETATE | NORETHINDRONE ACETATE | TABLET;ORAL | 5MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0179-0227 | Norethindrone Acetate | Norethindrone Acetate | KAISER FOUNDATION HOSPITALS | ANDA | Current |
| 68462-304 | Norethindrone Acetate | Norethindrone Acetate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-304 | Norethindrone Acetate | Norethindrone Acetate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-304 | Norethindrone Acetate | Norethindrone Acetate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |